Sunrise For Sunscreen Innovation Act – FDA Seeks Comment On TEA Decisions
This article was originally published in The Tan Sheet
Executive Summary
Under the Sunscreen Innovation Act, FDA’s tentative determinations on sunscreen ingredients TEAs are deemed proposed orders and must be made available for comment. The agency seeks input on six insufficient-data letters issued to sunscreen TEA sponsors in 2014.
You may also be interested in...
BASF Ingredient Suffers Identity Crisis In FDA Review
FDA says BASF must clarify whether tests studied bisoctrizole or the firm’s compound marketed as Tinosorb M, which combines bisoctrizole and other ingredients.
FDA Faults BASF Sunscreen Ingredient Data In Latest TEA Rejection
FDA advises BASF that the information the firm submitted is not sufficient to establish octyl triazone as GRASE. The agency’s third rejection this year of a sunscreen TEA could concern advocates on Capitol Hill and in the industry for using the process for adding ingredients to the OTC sunscreen monograph.
Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat
Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.